When investors think about brokerage arbitration, they often picture familiar stock-market disputes: a bad recommendation, excessive trading, or a sharp market drop in a publicly traded stock. But claims involving illiquid investments—such as non-traded REITs, non-publicly traded BDCs, private placements, and similar alternative products—often develop very differently.
That difference matters. Illiquid-investment cases frequently involve disputes over valuation, liquidity limits, account fit, due diligence, concentration, and disclosure in ways that ordinary stock cases often do not. In general terms, that can make these arbitrations more document-heavy, more fact-specific, and more dependent on what was said at the point of sale.
If you’re trying to understand why these cases feel different, this post will walk through the key distinctions. You’ll also see why investors in these matters often look for attorneys with documented experience handling highly similar claims, especially where the investment’s actual market value may have been difficult to see in real time.
For a broader foundation on these products themselves, it may help to start with this overview of illiquid alternative products and the risks that often come with them.
<aside> 💡 Scroll to the bottom for every post in this series.
</aside>
An illiquid investment is generally one that cannot be sold quickly at a transparent market price. Publicly traded stocks usually trade on an exchange, with continuously updated pricing and a ready pool of buyers and sellers. By contrast, many alternative investments do not trade on a national exchange, and investors may have limited ways to exit at all.
The SEC’s investor materials on non-traded REITs explain that, unlike exchange-traded REIT shares, non-traded REIT shares are not listed for trading on major exchanges and investor exit is often tied to a later liquidity event or a limited repurchase program rather than a daily public market. Likewise, the SEC’s bulletin on non-publicly traded BDCs notes that investors cannot sell those shares on an exchange and generally have fewer options to liquidate the position (Investor.gov on non-traded REITs; Investor.gov on non-publicly traded BDCs).
That basic structural feature changes a lot about a later dispute. In a public-stock arbitration, the parties can usually point to a market chart. In an illiquid-investment arbitration, the harder questions often include:
Publicly traded stock cases are not always simple, but they often involve clearer pricing evidence. A stock’s historical market price can be pulled from exchange records. The date of purchase, date of sale, trading volume, and price movement are usually straightforward. That can narrow the dispute to familiar issues like suitability, concentration, unauthorized trading, margin use, or misrepresentations.
Illiquid cases often lack that same transparency. FINRA has long emphasized that firms recommending complex or non-conventional investments are expected to understand the product, conduct due diligence, perform a reasonable-basis analysis, evaluate customer-specific suitability, provide balanced risk disclosures, maintain controls, and train representatives appropriately (FINRA Notice to Members 03-71; FINRA Regulatory Notice 12-03; FINRA Regulatory Notice 08-82).
That is one reason these arbitrations often turn into a deeper examination of the sales process, not just the investment’s later performance.